Ovid Therapeutics
OVID
$0.47
Share price
-6.57%
Change (1 day)
-90.44%
Change (1 year)
Categories
EPS for Ovid Therapeutics (OVID)
EPS in 2023 (TTM): -$1.05
According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.16. In 2022 the company made an earnings per share (EPS) of -$1.28 a decrease over its 2021 EPS that were of $2.94.
EPS history for Ovid Therapeutics from 2016 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.05 | -17.81% |
| 2022 | -$1.28 | -143.5% |
| 2021 | $2.94 | -226.43% |
| 2020 | -$2.32 | -11.39% |
| 2019 | -$2.62 | -25.47% |
| 2018 | -$3.52 | -23.94% |
| 2017 | -$4.63 | 143.74% |
| 2016 | -$1.90 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$3.62 | 211.43% | 🇺🇸 USA |